Confirmation that somatic mutations of beta-2 microglobulin correlate with a lack of recurrence in a subset of stage II mismatch repair deficient colorectal cancers from the QUASAR trial.
Histopathology 2019 May .
Barrow P, Richman S D, Wallace A, Handley K, Hutchins G G A, Kerr D, Magill L, Evans D G, Gray R, Quirke P, Hill
Microsatellite instability and Beta2-Microglobulin mutations as prognostic markers in colon cancer: results of the FOGT-4 trial.
British journal of cancer 2012 Mar 106 (6): 1239-45.
Tikidzhieva A, Benner A, Michel S, Formentini A, Link K-H, Dippold W, von Knebel Doeberitz M, Kornmann M, Kloor